May 26, 2017
Scott Gottlieb, M.D., has ended the hiring freeze President Donald Trump imposed on the FDA. The action means FDA commissioner Gottlieb can fill vacancies to shape an agency capable of enacting his plans for how safety and efficacy information are gathered during development. Trump imposed..
May 26, 2017
Biogen, the state’s largest local drug company by market cap and headcount, is about to lose yet another top executive. Kenneth DiPietro plans to step down as executive vice president of human resources tomorrow, a spokesman for the Cambridge drugmaker told the Boston Business Journal..
May 25, 2017
Alexion has announced that four members of the company’s C-suite team are set to leave the company, following an internal investigation into sales practices. Chief financial officer Dave Anderson is among the casualties, who while just joining the company this past December is set to..
May 25, 2017
After 112-years of Australian ownership Ansell will sell its condom business to a Chinese consortium for $800 million. Ansell says the time is right to exit the fluctuating sexual wellness market and focus on rubber gloves. Ansell’s history dates back to 1905, when Eric Norman..
Sometimes adult life sends us through a disturbing time warp. It’s much too reminiscent of high school. The cool kids’ cafeteria table (or parking lot, where I grew up) becomes the cool grown-up party at J.P. Morgan, for instance. Step into biopharma Twitter, where the..
Just days after announcing plans to ax 500 jobs in Switzerland, Novartis said another 250 jobs will be eliminated in the U.S., most at its headquarters in New Jersey with some of those headed to a service center in India. The company filed a WARN..
President Donald Trump’s administration has released a breakdown of its attempts to cut back on healthcare and research spending across the government, with proposed cuts to governmental biomedical research centers and the drugs regulator laid down in the fleshed-out budget. The document (available via the..
Bioverativ has struck a deal to buy True North Therapeutics. The deal will see the Biogen spinout pay $400 million upfront and up to $425 million in milestones to acquire the rare disease biotech and its clinical-phase treatment for cold agglutinin disease (CAD), TNT009. If..
Alexion Pharmaceuticals Inc. continues to reshape its top-level management after the company was hit by an internal investigation into its sales practices. Alexion will start a search for a new Chief Financial Officer after current CFO Dave Anderson announced he will resign at the end..
May 23, 2017
As a variety of states weigh measures targeting pharmaceutical pricing, Nevada’s Senate has passed a tough new bill that would publicly spotlight insulin makers’ price hikes and profits. Approved by the Nevada Senate on Friday, the bill would force diabetes drugmakers to disclose information on..